VIM and non-small cell lung carcinoma: Very interestingly, EndMT is also described for circulating tumor endothelial cells: double-positive circulating tumor endothelial cells (CD31+-vimentin+) were found in blood samples from patients with non- small-cell-lung cancer (NSCLC) [23].